Opinion on the diagnosis and treatment of human trichinellosis

Expert Opinion on Pharmacotherapy

Volumn 3, Issue 8, 2002, Pages 1117-1130

  Dupouy Camet, Jean ^a   Kocieka, Wanda ^a   Bruschi, Fabrizio ^a   Bolas Fernandez, Francisco ^a   Pozio, Edoardo ^a  

^a Université R Descartes ^*  (France)

Author keywords

Albendazole; Clinical diagnosis; Eosinophilia; Humans; Laboratory diagnosis; Mebendazole; Muscular enzymes; Serodiagnosis; Steroids; Treatment; Trichinellosis

Indexed keywords

ALBENDAZOLE; ANALGESIC AGENT; ANTHELMINTIC AGENT; BENZIMIDAZOLE; CIMETIDINE; CREATINE KINASE; CYCLODEXTRIN; DEXAMETHASONE; DIETHYLENE GLYCOL MONOETHYL ETHER; FLUBENDAZOLE; GLUCOCORTICOID; IVERMECTIN; MEBENDAZOLE; NONSTEROID ANTIINFLAMMATORY AGENT; POVIDONE; PREDNISOLONE; PREDNISONE; PYRANTEL; THIAMAZOLE; TIABENDAZOLE;

ABDOMINAL PAIN; ADULT; CHILL; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG FORMULATION; ENCEPHALITIS; FACE EDEMA; FEVER; HEADACHE; HUMAN; HYPEREOSINOPHILIA; MAJOR CLINICAL STUDY; MUSCLE BIOPSY; MYALGIA; MYOCARDITIS; PATHOPHYSIOLOGY; PREGNANCY; RASH; REVIEW; SENSORY DYSFUNCTION; SYMPTOMATOLOGY; THROMBOEMBOLISM; TRICHINOSIS; VERTIGO; ANIMAL; CHILD; EXPERT WITNESS; FEMALE; HOSPITALIZATION; RANDOMIZED CONTROLLED TRIAL;

ADULT; ALBENDAZOLE; ANIMAL; ANTHELMINTICS; CHILD; EXPERT TESTIMONY; FEMALE; HUMAN; PREGNANCY; RANDOMIZED CONTROLLED TRIALS; SEVERITY OF ILLNESS INDEX; THIABENDAZOLE; TRICHINOSIS; ANIMALS; HUMANS;

EID: 0035989251     PISSN: 14656566     EISSN: None     Source Type: Journal    
DOI: 10.1517/14656566.3.8.1117     Document Type: Review

References (85)

1. New patterns of Trichinella infections
2. Factors affecting the flow among domestic, synanthropic and sylvatic cycles of Trichinella
3. The systematics of the genus Trichinella with a key to species
4. Host diversity and biological characteristics of the Trichinella genotypes and their effect on transmission
5. Trichinellosis: A worldwide zoonosis
6. Trichinellosis: The zoonosis that won't go quietly
7. Biology
8. Two familial outbreaks of trichinellosis in the Languedoc region of France due to ingestion of wild boar meat
9. Clinical trichinellosis
10. Clinical aspects of infection with Trichinella spp
11. Trichinellosis: Human disease, diagnosis and treatment
12. Chronic trichinosis. Clinical, bioptic, serological and electromyographic observations
13. Neurotrichinosis. A cerebrovascular disease associated with myocardial injury and hypereosinophilia
14. Four outbreaks of human trichinellosis in Henan province
15. Aspects cliniques de l'épidémie de trichinose d'août 1985 à Melun et Paris
16. Two outbreaks of trichinosis caused by horsemeat in France in 1985
17. A multifocal outbreak of trichinellosis linked to horse meat imported from North America to France in 1993
18. Cardiac involvement in trichinosis
19. Trichinosis with ventilatory failure and persistent myocarditis
20. Multifocal central nervous system lesions in three patients with trichinosis
21. Difficulties in diagnosing Trichinella encephalitis
22. Trichinosis
23. MRI in a case of neurotrichinosis
24. Clinical aspects in man
25. Trichinelloses
26. Arctic trichinosis presenting as prolonged diarrhea
27. Trichinosis in the Canadian Arctic: Report of five outbreaks and a new clinical syndrome
28. Clinical analysis and evaluation of selected laboratory parameters in patients examined in distant periods after trichinellosis
29. Trichinosis: A prospective controlled study of patients ten years after acute infection
30. Trichinosis
31. Trichinose humaine et immunodépression. Un cas chez un greffé rénal
32. Trichinosis mimicking polymyositis in a patient with human immunodeficiency virus infection
33. Trichinosis in an immunosuppressed human host
34. New aspects of human trichinellosis: The impact of new Trichinella species
35. Comparison of human trichinellosis caused by Trichinella spiralis and by Trichinella britovi
36. Trichinella murrelli: Pathological features in human muscles at different delays after infection
37. First outbreak of human trichinellosis caused by Trichinella pseudospiralis
38. Trichinella pseudospiralis outbreak in France
39. Prospective rheumatological study of muscle and joint symptoms during Trichinella nelsoni infection
40. Detection of specific immunoglobulins (IgG IgM, IgA, IgE) and total IgE levels in human trichinosis by means of the enzyme-linked immunosorbent assay (ELISA)
41. Immunodiagnosis in man
42. Parasite-specific antibody response in Trichinella sp. 3 human infection: A one year follow-up
43. The use of a synthetic antigen for the serological diagnosis of human trichinellosis
44. Diagnosis of human trichinellosis: Pitfalls in the use of a unique immunoserological technique
45. Comparative evaluation of a latex agglutination test, two Elisa kits and a western blot kit for the serodiagnosis of human trichinellosis
46. The value of enzyme-linked immunosorbent assay (ELISA) for diagnosis of human trichinosis
47. Molecular and biochemical methods for parasite differentiation within the genus Trichinella
48. Trichinella spiralis: Induction of the basophilic transformation of muscle cells by synchronous newborn larvae
49. International Commission on Trichinellosis: Recommendations on methods for the control of Trichinella in domestic and wild animals intended for human consumption
50. New aspects of clinical pathology and electrophysiological muscle disturbances in patients with history of trichinellosis
51. Anthelmintic and histopathological effects of mebendazole on Trichinella spiralis in the rat
52. Efficacy of mebendazole and albendazole against Trichinella spiralis in mice
53. The influence of immunomodulating drugs (niridazole and cyclophosphamide) on the effect of mebendazole on encysted larvae of Trichinella spiralis
54. Chemotherapy
55. The efficacy of flubendazole against Trichinella spiralis in swine
56. Trial of ivermectin against the muscle phase of trichinellosis in mice
57. The effect of a single injection of ivermectin on encysted muscle larvae of Trichinella spiralis in experimentally infected pigs
58. Randomized trial of albendazole versus thiabendazole plus flubendazole during an outbreak of human trichinellosis
59. Albendazole versus thiabendazole as therapy for trichinosis: A retrospective study
60. Blinded placebo-controlled trial of antiparasitic drugs for trichinosis myositis
61. Hand rash in trichinosis
62. Clinical pharmacokinetics of high dose mebendazole in patients treated for cystic hydatid disease
63. Cimetidine increases serum mebendazole concentrations. Implications for treatment of hepatic hydatid cysts
64. Anthelmintics/mebendazole
65. Effect of mebendazole therapy during pregnancy on birth outcome
66. Intestinal parasitosis in the immunocompetent child
67. Etiotropic therapy and prophylaxis of trichinellosis
68. Effect of early prophylactic therapy in patients infected with T. spiralis
69. Therapeutical properties of benzimidazoles in trichinellosis and the side effects of the treatment
70. Failure of mebendazole in treating Trichinella spiralis infection in humans at the stage of encapsulating larvae
71. Treatment of trichinellosis with mebendazole
72. Pharmacokinetics of albendazole in man
73. Increased systemic availability of albendazole when taken with a fatty meal
74. Clinical pharmacokinetics of albendazole in patients with brain cysticercosis
75. Clinical evaluation of albendazole in the therapy of human trichinellosis
76. Chemotherapy of Echinococcus infection in man with albendazole
77. Anthelmintics/albendazole
78. The use of antiprotozoan and anthelmintic drugs during pregnancy and contraindications
79. Albendazole and pregnancy
80. Assessing the risk of benzimidazole during pregnancy
81. Improvement of albendazole efficacy against enteral but not against parenteral stages of Trichinella spiralis by preparing solid dispersions on polyvinylpyrrolidone
82. A novel formulation of albendazole solution: Oral bioavailability and efficacy evaluation
83. Preparation and characterization of albendazole-cyclodextrin complexes
84. Methimazole-mediated enhancement of albendazole oral bioavailability and anthelmintic effects against parenteral stages of Trichinella spiralis in mice: The influence of the dose regime
85. Dexamethasone increases plasma levels of albendazole